EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Chemokine expression modulations in primary and metastatic colorectal cancer

Syeda Faiza, Afraz Numan, Martin R. Berger, Asim Pervaiz

Biomedical Current Insights · 2024

DOI: 10.63626/af842r87 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomedical Current Insights, 2024. Verfasst von Syeda Faiza und 3 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Chemokine are small proteins primarily involved in cell movement, immune response, inflammation and tissue repair. Chemokine also plays an important role in disease conditions including cancer growth. The objective of this study was to analyze expressional modifications in the chemokine in primary and metastatic colorectal cancer by using clinical isolates and in vivo model respectively.

Methods

Serum samples from a total of 40 colorectal cancer patients (stage II and III) and healthy controls were collected following the due ethical codes. Circulatory levels of the chemokine (CCL family) were quantified using enzyme-linked immunosorbent assay (ELISA). To investigate metastasis associated expression changes of the chemokine, colorectal cancer animal model and microarray methodologies were exploited.

Results

Increased circulatory levels of CCL2, CCL17 and CCL22 were detected in stage II and III colorectal cancer patients when compared with healthy controls. In contrast, CCL11 levels were substantially low in colorectal cancer patients. As far as rat animal model for colorectal cancer liver metastasis is concerned, only CCL2 levels were considerably high during the early phase of colorectal cancer cells’ implantation (Day 03) into the liver. Other chemokines did not demonstrate noticeable de-regulation during the whole period of experimental procedures (up to Day 21).

Conclusion

Differential circulatory levels of chemokine were detected in colorectal cancer patients and healthy controls. Liver metastasis of colorectal cancer cells was accompanied by a marked increase of CCL2 during early phase of settlement. The findings reflected a discrete change in the circulatory and metastasis associated with chemokine profile in colorectal cancer.

Zitieren

APA

Faiza, S., Numan, A., Berger, M. R., & Pervaiz, A. (2024). Chemokine expression modulations in primary and metastatic colorectal cancer. Biomedical Current Insights. https://doi.org/10.63626/af842r87

Vancouver

Faiza S, Numan A, Berger MR, Pervaiz A. Chemokine expression modulations in primary and metastatic colorectal cancer. Biomedical Current Insights. 2024. doi:10.63626/af842r87

BibTeX
@article{Faiza2024,
  author = {Faiza, Syeda and Numan, Afraz and Berger, Martin R. and Pervaiz, Asim},
  title = {Chemokine expression modulations in primary and metastatic colorectal cancer},
  journal = {Biomedical Current Insights},
  year = {2024},
  doi = {10.63626/af842r87}
}
Kostenlos starten →